Cargando…
Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after k...
Autores principales: | Li, Yin, Sha, Zixin, Peng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/ https://www.ncbi.nlm.nih.gov/pubmed/34733559 http://dx.doi.org/10.1155/2021/5497346 |
Ejemplares similares
-
Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities
por: Masson, Jesse JR, et al.
Publicado: (2017) -
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022) -
Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021) -
Metabolic reprogramming heterogeneity in chronic kidney disease
por: Miguel, Verónica, et al.
Publicado: (2023) -
Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities
por: Alramadhani, Dina, et al.
Publicado: (2022)